OR WAIT 15 SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
July 02, 2019
The increasing growth in the cell- and gene-therapy markets is inspiring CDMOs to expand their services in this emerging biologic drug arena.
May 02, 2019
FDA inspections can create uncertainty. Supervision of the contract manufacturer
is crucial in ensuring compliance.
March 02, 2019
Single-use systems can be a cost savings for CMOs, and these savings can be passed on to clients and, ultimately, to patients.
January 02, 2019
Outsourcing of manufacturing activities is expected to increase in 2019.
November 02, 2018
The growth in adoption of single-use systems for commercial manufacturing will be dramatic in coming years.
September 02, 2018
Partnerships, mergers, and new services indicate that biologics are continuing to influence CMOs’ and CDMOs’ decisions to expand their biopharmaceutical services.
July 02, 2018
This article highlights 15 years of changes in biopharmaceutical manufacturing.
June 02, 2018
New and expanded facilities point to the continuing growth of the biopharmaceutical industry.
May 02, 2018
CDMOs can claim credit for the robust growth of emerging bio/pharma financings.
March 02, 2018
Development and adoption of new technologies create challenges that may take years to resolve.